Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Thursday, December 13, 2018 · 470,978,973 Articles · 3+ Million Readers

Eubiotics Market Estimated To Reach at USD 8.60 billion in 2026 says a new report by Polaris Market Research

Eubiotics Market is expected to grow from USD 5.32 billion in 2017 to USD 8.60 billion by 2026, at a CAGR of 5.62% during the forecast period.

Eubiotics are the non antimicrobial products that specifically maintain a healthy balance between good bacteria and pathogens or eubiosis in the digestive track”
— Polaris Market Research

BROOKLYN, NY, UNITED STATES, February 15, 2018 / -- According to a study published by Polaris Market Research, the global prebiotic ingredients market generated USD 5.32 billion in 2017 and is anticipated to grow at a CAGR of 5.62% during the forecast period.

Eubiotics are the non antimicrobial products that specifically maintain a healthy balance between good bacteria and pathogens or eubiosis in the digestive track. Ban on use of antibiotics in animal feed is the foremost reason for the growth of eubiotics market as these products are the only similar options available to be used as alternatives for antibiotics.

Some of the functional advantages that these products offer rather than only being a substitute include the economical adhesion for probiotic microorganisms to the epithelial receptors possibly will prevent attachment of the pathogenic bacteria, higher rate of synthesis of lactic acid and reduction of intestinal pH, aggregation of these pathogenic bacteria and eubiotics, production of a specific antibacterial substance, reduction in production of toxic amines and decrease in ammonia level in gastro-intestinal tract, help in beneficial reactions in the immune system of the intestine, which is an improved intestinal defence against viral infections.

Moreover, prebiotics that is one of the other common eubiotics is based on feeding of some certain non-digestible oligosaccharides to manipulate or control microbial composition, thereby helping in maintaining a beneficial microflora. Usually dietary inclusion range of these products is within 0.1 to 0.5%. Few of the primary functions of these products include selective control of the intestinal microflora, reduction of several pathogens and the promotion of various beneficial microorganisms. These restrict to immense gastric acidity situations, simplify hydrolysis by the digestive enzymes and also for gastrointestinal absorption, initiate fermentation by the intestinal microflora and provide selective stimulation for growth and other activities of intestinal bacteria that contribute to a healthily gut health. These benefits of eubiotics are expected to be the major factors driving the market.

The report provides an extensive qualitative and quantitative analysis of the market trends and growth prospects of the Global Eubiotics Market, 2017-2026. This report comprises a detailed geographic distribution of the market across North America, Europe, APAC and South America, and MEA. North America is further segmented into U.S., Canada. Europe is divided into Germany, UK, Italy, and Rest of Europe. Asia-Pacific is bifurcated into China, India, Japan, and Rest of Asia-Pacific.

Competitive Landscape and Key Vendors
Europe is projected to be the largest market by 2026. Spain was the first country to put a ban on antibiotics. In 2006, the European Union banned using the remaining feed antibiotics namely flavophospholipol, salinomycin-Na, avilamycin and monensin-Na. This created an immense demand for eubiotics especially for the farm animals.

North America region also experience stringent regulations; however it’s still a growing market. Asia Pacific is expected to witness the fastest market growth owing to increasing number of feed processors in the region. The mounting surge in meat processors and shift in consumer demand for organic food products have be identified as some of the major factors responsible for driving the regional market.

Some of the leading industry participants include BASF SE, Cargil, Koninklijke DSM N.V., Novozymes, Kemin Industries, Inc., Addcon, Novus International, Inc., Lallemand, Inc., Beneo Group and Chr. Hansen Holding A/S.

Key Segments

Segment – 1. Ingredient Type

1.1 Prebiotics
1.2 Probiotics
1.3 Organic Acids
1.4 Essential Oil

Segment – 2. Functionality

2.1 Yield
2.2 Productivity
2.3 Immunity
2.4 Nutrition & Gut Health

Segment – 3. Application

3.1 Poultry
3.2 Cattle
3.3 Aquaculture
3.4 Swine

Segment – 4. Region

4.1 North America
4.1.1 U.S.
4.1.2 Canada

4.2 Europe
4.2.1 Germany
4.2.2 UK
4.2.3 France

4.3 Asia-Pacific
4.3.1 China
4.3.2 India
4.3.3 Japan

4.4 Latin America
4.4.1 Brazil
4.4.2 Mexico

4.5 Middle East and Africa

Browse other reports by Polaris Market Research:

Polaris Market Research & Consulting
email us here

Powered by EIN Presswire

EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release